Drug Delivery Nanoparticles: Toxicity Comparison in Retinal Pigment Epithelium and Retinal Vascular Endothelial Cells

REFERENCES

• Gao H, Yang Z, Zhang S, et al. Internalization and subcellular fate of aptamer and peptide dual-functioned nanoparticles. J Drug Target 2014;22(5):450–459
   PubMed Web of Science ®Google Scholar
• Shi J, Votruba AR, Farokhzad OC, Langer R. Nano-technology in drug delivery and tissue engineering: from discovery to applications. Nano Lett 2010;10(9):3223–3230
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent Smancs. Cancer Res 1986;46(12 Part 1):6387–6392
   PubMed Web of Science ®Google Scholar
• Eifler AC, Thaxton CS. Nanoparticle therapeutics: FDA approval, clinical trials, regulatory pathways, and case study. Methods Mol Biol 2011;726(21):325–338
   PubMedGoogle Scholar
• Kim JH, Kim JH, Kim K-W, et al. Intravenously administered gold nanoparticles pass through the blood–retinal barrier depending on the particle size, and induce no retinal toxicity. Nanotechnology 2009;20(50):505101
   PubMed Web of Science ®Google Scholar
• Varshochian R, Riazi-Esfahani M, Jeddi-Tehrani M, et al. Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment. J Biomed Mater Res A 2015;103(10):3148--3156. doi:10.1002/jbm.a.35446
   PubMed Web of Science ®Google Scholar
• Farjo KM, Ma J-X. The potential of nanomedicine therapies to treat neovascular disease in the retina. J Angiogenes Res 2010;2(1):21
   PubMedGoogle Scholar
• Diebold Y, Calonge M. Applications of nanoparticles in ophthalmology. Prog Retin Eye Res 2010;29(6):596–609
   PubMed Web of Science ®Google Scholar
• Strettoi E, Gargini C, Novelli E, Sala G. Inhibition of ceramide biosynthesis preserves photoreceptor structure and function in a mouse model of retinitis pigmentosa. Proc Natl Acad Sci USA 2010;107(43):18706–18711
   PubMed Web of Science ®Google Scholar
• Chen Y-S, Green CR, Wang K, Danesh-Meyer HV, Rupenthal ID. Sustained intravitreal delivery of connexin43 mimetic peptide by poly(d,l-lactide-co-glycolide) acid micro- and nanoparticles—Closing the gap in retinal ischaemia. Eur J Pharm Biopharm 2015;107:378--386. doi:10.1016/j.ejpb.2014.12.005
   Web of Science ®Google Scholar
• Jin J, Zhou KK, Park K, et al. Anti-inflammatory and antiangiogenic effects of nanoparticle-mediated delivery of a natural angiogenic inhibitor. Invest Ophthalmol Vis Sci 2011;52(9):6230–6237
   PubMed Web of Science ®Google Scholar
• Kim H, Csaky KG. Nanoparticle-integrin antagonist C16Y peptide treatment of choroidal neovascularization in rats. J Control Release 2010;142(2):286–293
   PubMed Web of Science ®Google Scholar
• Singh SR, Grossniklaus HE, Kang SJ, et al. Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV. Gene Ther 2009;16(5):645–659
   PubMed Web of Science ®Google Scholar
• Song CX, Labhasetwar V, Murphy H, Qu X, Humphrey WR, Shebusk RJ, Levy RJ. Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery. J Control Release 1997;43(2--3):197--212. doi:10.1016/S0168-3659(96)01484-8
   Web of Science ®Google Scholar
• Kim I, Byeon HJ, Kim TH, et al. Doxorubicin-loaded highly porous large PLGA microparticles as a sustained-release inhalation system for the treatment of metastatic lung cancer. Biomaterials 2012;33(22):5574–5583
   PubMed Web of Science ®Google Scholar
• Wang W, Xiong W, Wan J, et al. The decrease of PAMAM dendrimer-induced cytotoxicity by PEGylation via attenuation of oxidative stress. Nanotechnology 2009;20(10):105103
   PubMed Web of Science ®Google Scholar
• Matsumura S, Sato S, Yudasaka M, et al. Prevention of carbon nanohorn agglomeration using a conjugate composed of comb-shaped polyethylene glycol and a peptide aptamer. Mol Pharm 2009;6(2):441–447
   PubMed Web of Science ®Google Scholar
• Eck W, Craig G, Sigdel A, et al. PEGylated gold nanoparticles conjugated to monoclonal F19 antibodies as targeted labeling agents for human pancreatic carcinoma tissue. ACS Nano 2008;2(11):2263–2272
   PubMed Web of Science ®Google Scholar
• Mano SS, Kanehira K, Sonezaki S, Taniguchi A. Effect of polyethylene glycol modification of tio2 nanoparticles on cytotoxicity and gene expressions in human cell lines. Int J Mol Sci 2012;13(3):3703–3717
   PubMed Web of Science ®Google Scholar
• Prencipe G, Tabakman SM, Welsher K, et al. PEG branched polymer for functionalization of nanomaterials with ultralong blood circulation. J Am Chem Soc 2009;131(13):4783–4787
   PubMed Web of Science ®Google Scholar
• Veronese FM, Harris JM. Introduction and overview of peptide and protein pegylation. Adv Drug Deliv Rev 2002;54(4):453–456
   PubMed Web of Science ®Google Scholar
• Moret F, Selvestrel F, Lubian E, et al. PEGylation of ORMOSIL nanoparticles differently modulates the in vitro toxicity toward human lung cells. Arch Toxicol 2015;89(4):607–620
   PubMed Web of Science ®Google Scholar
• Peracchia MT, Fattal E, Desmaële D, et al. Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. J Control Release 1999;60(1):121–128
   PubMed Web of Science ®Google Scholar
• Sahu D, Kannan GM, Vijayaraghavan R. Carbon black particle exhibits size dependent toxicity in human monocytes. Int J Inflam 2014;2014(2):827019–10
   PubMedGoogle Scholar
• Hu Y, Xie J, Tong YW, Wang C-H. Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells. J Control Release 2007;118(1):7–17
   PubMed Web of Science ®Google Scholar
• Kulkarni SA, Feng S-S. Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery. Pharm Res 2013;30(10):2512–2522
   PubMed Web of Science ®Google Scholar
• Firdessa R, Oelschlaeger TA, Moll H. Identification of multiple cellular uptake pathways of polystyrene nanoparticles and factors affecting the uptake: relevance for drug delivery systems. Eur J Cell Biol 2014;93(8–9):323–337
   PubMed Web of Science ®Google Scholar
• Chu Z, Zhang S, Zhang B, et al. Unambiguous observation of shape effects on cellular fate of nanoparticles. Sci Rep 2014;4:4495
   PubMed Web of Science ®Google Scholar